What sector is OBIO in?

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) operates in the Technology sector, specifically in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

What is OBIO's market cap?

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) has a market capitalization of $228M.

How can I analyze OBIO stock?

Valhalla provides comprehensive analysis for OBIO including institutional trade flow, dark pool activity, options data, technical indicators, and proprietary scoring. Visit valhalla-labs.io/stocks/OBIO for a full breakdown.

Where can I find institutional trades for OBIO?

Valhalla tracks real-time institutional trade flow for OBIO, including dark pool blocks, lit block trades, and sweep orders. These insights help identify where smart money is positioned.

OBIO

Q: What is OBIO (Orchestra BioMed Holdings, Inc. Ordinary Shares)?

Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) is a technology company in the surgical & medical instruments & apparatus industry. Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hyper

Orchestra BioMed Holdings, Inc. Ordinary Shares

Technology — SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Valhalla Score 56

$3.96

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Latest News

FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM TherapyAtrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertension despi...globenewswire.com — Apr 30, 2026

OBIO Data Insights

Dark pool activity detected in the last 5 trading days

Subscribe for full dark pool analysis, institutional flow, and real-time alerts.

📊 Key Statistics

Market Cap$228M

P/E Ratio—

EPS (TTM)—

EPS YoY—

Revenue YoY—

Float—

Short Float %—

Inst. Ownership—

Sector RS—

📈 Fundamentals

ROE—

ROIC—

ROA—

Current Ratio—

Debt/Equity—

Gross Margin—

Net Margin—

Dividend Yield—

Next Earnings—

⚡ Options Summary

Call OI—

Put OI—

P/C Ratio (OI)—

Gamma Environment—

Max Pain—

Call Wall—

Put Wall—

🎯 Analyst Estimates

Consensus Target—

High Target—

Low Target—

Analysts—

Upside/Downside—

📋 Quarterly Financials

Period	Revenue	Rev YoY	EPS	EPS YoY	Gross Margin

Start Free Trial See full options flow, dark pool data & more

🔥 Recent Options Flow

Type	Strike	Exp	Size	Premium	Time

Start Free Trial Institutional trades, dark pool vs lit exchange

🏛️ Institutional Trades

Type	Price	Size	Value	Venue	Time

Start Free Trial Full insider & congressional trade history

👤 Insider Trades

Name	Type	Shares	Price	Date

Start Free Trial Top institutional holders & ownership data

🏦 Top Institutional Holders

Institution	Shares	Value	% of Class